Woman and Man
- | Country :
- France
- | organs : -
- | Specialty : -
Extract
This trial is a phase I, open-label, dose-escalating study of the safety or percutaneous intra-tumoral injection of TG4023 (MVA-FCU1) combined with systemic administration of 5-fluorocytosine in patients with primary or secondary hepatic tumors.
Inclusion criteria
- Hepatocellular carcinoma